China Questions Pfizer about Anti-Competitive Practices

China's National Development and Reform Commission has begun investigating anti-competition practices, asking foreign and domestic medical products companies to answer questions. According to the China Daily, Pfizer is the only named company so far to have been asked for data, though the paper pointed out the questions do not mean Pfizer is guilty. China is very concerned about keeping a lid on the huge cost of providing healthcare to its citizens. More details.... Stock Symbol: (NYSE: PFE) Share this with colleagues: // //